Related references
Note: Only part of the references are listed.Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial
John E. A. Blair et al.
EUROPEAN HEART JOURNAL (2011)
Cardiorenal Syndrome New Perspectives
Jeremy S. Bock et al.
CIRCULATION (2010)
Role of remission clinics in the longitudinal treatment of CKD
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Renal insufficiency and heart failure - Prognostic and therapeutic implications from a prospective cohort study
FA McAlister et al.
CIRCULATION (2004)
Continuum of renoprotection with Losartan at all stages of type 2 diabetic nephropathy:: A post hoc analysis of the RENAAL trial results
G Remuzzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Preventing microalbuminuria in type 2 diabetes
P Ruggenenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
